TOFACITINIB INDUCES CLINICAL AND ENDOSCOPIC REMISSION IN BIOLOGIC REFRACTORY ULCERATIVE COLITIS PATIENTS: A REAL-WORLD BELGIUM COHORT STUDY

被引:0
|
作者
Cremer, Anneline
Lobaton, Triana
Vieujean, Sophie
Bossuyt, Peter
Rahier, Jean-Francois
Baert, Filip J.
Dewit, Olivier
Macken, Elisabeth
Somers, Michael
Vijverman, Anne
Van Hootegem, Philippe
Mana, Fazia
Willandt, Barbara
Caenepeel, Philip
Humblet, Evelien
D'Heygere, Francois
Verreth, Annelies
El Nawar, Abdo
Coenegrachts, Jean-Louis
Dewit, Sophie
De Coninck, Steven
Schoofs, Nele
Delen, Stefan
Dutre, Joris
Thienpont, Clara
Vanden Branden, Stijn
Staessen, Dirk
Franchimont, Denis
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1895
引用
收藏
页码:S1208 / S1208
页数:1
相关论文
共 50 条
  • [41] Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience
    Kotwani, Prashant
    Terdiman, Jonathan
    Lewin, Sara
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07): : 1026 - 1028
  • [42] Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study
    Honap, S.
    Sharma, E.
    Ray, S.
    Mawdsley, J.
    Anderson, S.
    Samaan, M.
    Pavlidis, P.
    Irving, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I510 - I510
  • [43] Safety analysis of tofacitinib in ulcerative colitis: Real-world outcomes from a three-year UK observational cohort study
    Honap, S.
    Sharma, E.
    Ray, S.
    Mawdsley, J.
    Anderson, S.
    Samaan, M.
    Pavlidis, P.
    Irving, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I510 - I510
  • [44] Effectiveness of upadacitinib for induction of remission in moderate-to-severe ulcerative colitis: real-world clinical outcomes appear independent of prior tofacitinib exposure
    Gonzalez, A. Elosua
    Zabalza, L.
    Vicuna, M.
    Rubio, S.
    Nantes, O.
    Rodriguez, C.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1295 - i1295
  • [45] Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis
    Gros, Beatriz
    Goodall, Mairi
    Plevris, Nik
    Constantine-Cooke, Nathan
    Elford, Alexander T.
    O'Hare, Claire
    Noble, Colin
    Jones, Gareth-Rhys
    Arnott, Ian D.
    Lees, Charlie W.
    JOURNAL OF CROHNS & COLITIS, 2023,
  • [46] Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis
    Bermejo, F
    López-Sanromán, A
    Hinojosa, J
    Castro, L
    Jurado, C
    Gómez-Belda, AB
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (02) : 94 - 97
  • [47] Predictors of Endoscopic Inflammation in Patients With Ulcerative Colitis in Clinical Remission
    Rosenberg, Laura
    Lawlor, Garrett O.
    Zenlea, Talia
    Goldsmith, Jeffrey D.
    Gifford, Anne
    Falchuk, Kenneth R.
    Wolf, Jacqueline L.
    Cheifetz, Adam S.
    Robson, Simon C.
    Moss, Alan C.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 779 - 784
  • [48] REAL-WORLD EXPERIENCE WITH TOFACITINIB DOSE DE-ESCALATION IN PATIENTS WITH MODERATE AND SEVERE ULCERATIVE COLITIS
    Yu, Amy
    Shi, Bingyan
    Ha, Nghiem
    Beck, Kendall
    GASTROENTEROLOGY, 2023, 164 (04) : S102 - S102
  • [49] Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis
    Yu, Amy
    Ha, Nghiem B.
    Shi, Bingyan
    Cheng, Yao-Wen
    Mahadevan, Uma
    Beck, Kendall R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (12) : 3115 - +
  • [50] Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
    Taxonera, Carlos
    Olivares, David
    Alba, Cristina
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 32 - 40